Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Str8Shooter88on Apr 27, 2016 1:03pm
51 Views
Post# 24815815

RE:RE:eod .25

RE:RE:eod .25Indeed nice to have a ticket to the show! I bought in at .13 on the first run, and sold in the mid .20's, then bought back in at .135 on the second run up, sold again in the low .20's...and then got back in at .155 and have been holding ever since...and plan to hold this until full value is realized (at least in my opinion anyway)...which I feel is way higher than where we sit today...as into the $$$ range.

Kick azz turn around story unfolding here before our very eyes. And yes, I agree with jerrio78, that this will go A LOT higher once news comes. Risky? Yes. High reward? YES YES! The longs with ballz of steel will prosper nicely from this one! Management is so far executing on their word. 

jerrio78 wrote:
There are some good sized buy orders right now but someone looks like they are trying to herd the sellers into the bid by putting up a good sized ask at 23. I like the strategy but the lack of sellers running at the bid shows you the small flippers are probably gone and the newer retail crwod got flushed out in the teens. I think the longs holding have been in contact with the company and know whats happening, hence the lack of sellers. The sedar filings are telling as well. I think we will go a lot higher than most expect when news breaks. Its nice to have a ticket to the show. Enjoy your morning folks.


Bullboard Posts